Lyfebulb partners with Dance Biopharm to host a Diabetes focused event

On July 15th, 2015 we celebrated our 10th Social Club and gathered a unique group of people interested in improving the lives of those impacted by Diabetes.  This Diabetes awareness event was co-hosted with Dance Biopharm which is raising capital to accelerate its clinical development of a novel inhaled insulin that potentially could improve the convenience as well as the compliance for people living with Diabetes.  Speakers included Dr. Karin Hehenberger, CEO & Founder of Lyfebulb, Dr. John Patton, CEO of Dance Biopharm, Dr. Tyler Martin, President of Dance Biopharm, and Adam Stern, CEO of AegisStern Ventures.